Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

VCSH vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, VCSH returned +1.3% to XBI's +41.2%, and VCSH charges 0.03% to XBI's 0.35%.

askIQ about this page

askIQ about VCSH and XBI

Net assets: $43.9bn on Sep 30, 2026 for Vanguard Short-Term Corporate Bond ETF, and $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF.

At a glance
+1.3%
VCSH total return, 1 year
+41.2%
XBI total return, 1 year
0.03%
VCSH expense ratio
0.35%
XBI expense ratio

Pair scorecard

VCSH costs 0.32 points a year less; their one-year returns differ by 39.9 points; VCSH is 4.2 times larger.

VCSH vs XBI: Differences, Returns & Fees
MeasureVCSHXBI
Return
Total return, 1 year+1.3%+41.2%
Drawdown
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksBloomberg U.S. 1-5 Year Corporate Bond IndexBiotech
Cost and size
Expense ratio0.03%0.35%
Net assets, as of Sep 30, 2026$43.9bn$10.4bn
Active share vs the S&P 50098%
Holdings
Holdings in common0%
In the S&P 500, by weight13%
Top ten holdings, share of the fund18%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, VCSH and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first VCSH XBI
Only in one fund ↓
Only in VCSH
MKTLIQ 0.68%
Bank of America Corp 0.23%
Space Exploration Technologies Corp 0.22%
CVS Health Corp 0.20%
AbbVie Inc 0.20%
Amazon.com Inc 0.19%
Boeing Co 0.19%
T-Mobile USA Inc 0.19%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

VCSH Vanguard Short-Term Corporate Bond ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Bond ETF Thematic ETF
What it is Tracks an index of Short-Term Corporate Bond Biotech
Total return, 1 year +1.3% +41.2%
Its benchmark over the same days +1.3% (SCHJ) not measured
Gap to its benchmark 0.0 pts vs SCHJ not measured
Expense ratio 0.03% 0.35%
Holdings 3064 165
Net assets, VCSH as of Sep 30, 2026 and XBI as of Oct 27, 2026 $43.9bn $10.3bn

VCSH and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
VCSH

VCSH tracks an index of Short-Term Corporate Bond. Over the year to Oct 28, 2026 it returned +1.3% with distributions reinvested, against +1.3% for its benchmark, the Bloomberg U.S. 1-5 Year Corporate Bond Index. The prospectus expense ratio is 0.03% a year.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are VCSH and XBI in the same category?
VCSH is a bond ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, VCSH or XBI?
In the year to Oct 28, 2026, with distributions reinvested, VCSH returned +1.3% and XBI +41.2%.
Which is cheaper, VCSH or XBI?
VCSH is cheaper, by 0.32 percentage points a year. That is about $32 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, VCSH against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/vcsh-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.